Cargando…
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma
Among all types of kidney diseases, renal cell carcinoma (RCC) has the highest mortality, recurrence and metastasis rates, which results in high numbers of tumor-associated mortalities in China. Identifying a novel therapeutic target has attracted increasing attention. Bromodomain and extraterminal...
Autores principales: | Wan, Pei, Chen, Zhilin, Zhong, Weifeng, Jiang, Huiming, Huang, Zhicheng, Peng, Dong, He, Qiang, Chen, Nanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610328/ https://www.ncbi.nlm.nih.gov/pubmed/33125143 http://dx.doi.org/10.3892/or.2020.7796 |
Ejemplares similares
-
Prognostic Value of an m(5)C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma
por: Li, Hanrong, et al.
Publicado: (2021) -
BRDT promotes ovarian cancer cell growth
por: Chen, Ling, et al.
Publicado: (2020) -
Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang, Huiming, et al.
Publicado: (2021) -
Metformin blocks MYC protein synthesis in colorectal cancer via mTOR‐4EBP‐eIF4E and MNK1‐eIF4G‐eIF4E signaling
por: Shen, Peng, et al.
Publicado: (2018) -
Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023)